The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


1.57 Milligram Tablet Prolonged Release

Krka d.d., Novo mestoEU/1/08/469/038-041

Main Information

Active SubstancesPRAMIPEXOLE
Strength1.57 Milligram
Dosage FormTablet Prolonged Release
Licence HolderKrka d.d., Novo mesto
Licence NumberEU/1/08/469/038-041

Group Information

ATC CodeN04BC05 pramipexole


Licence Issued
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back